This is an advertisement
The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015. They now face thousands of lawsuits.
ClassAction.com is investigating possible Actemra lawsuits against Roche for allegedly failing to warn about heart, lung, and pancreatic side effects.
TDF drugs have been linked to kidney and bone injuries. Lawsuits allege that Gilead withheld a less toxic HIV drug in order to maximize profits.
Dozens of patients have filed lawsuits against AstraZeneca alleging the company failed to warn of Kombiglyze XR's heart failure risk.
Onglyza lawsuits allege that drugmaker AstraZeneca for years knew about heart failure risks but failed to adequately warn doctors and patients.
Lawsuits allege that drugmaker Sanofi hid Taxotere's permanent hair loss risks while falsely and illegally promoting the drug to increase profits.
Did Bayer/Johnson & Johnson overstate Xarelto's benefits while downplaying its bleeding risks? That's what thousands of Xarelto lawsuits claim.
More than 700 lawsuits allege that Victoza, Byetta, and Januvia increase patients' risk of pancreatic cancer. But manufacturers, plaintiffs allege, failed to warn doctors and patients.
Xarelto is marketed as being easier to use than warfarin. But Bayer's ads failed to mention that Xarelto may cause uncontrolled, irreversible bleeding.
Merck & Co. faces lawsuits over its shingles vaccine Zostavax, which plaintiffs allege may cause severe side effects like blindness and paralysis.
Testosterone therapy was allegedly marketed to men who suffer from "Low T," a vague condition that may have little scientific basis.
Abilify is used to treat depression, bipolar disorder, and schizophrenia. But evidence suggests that the drug may cause compulsive behaviors like gambling.
Tenofovir disoproxil fumarate (TDF) drugs like Truvada, Viread, Atripla, and Complera are linked to an increased risk of kidney disease and bone fractures.
Onglyza is linked to an increased risk of heart failure, heart attack, cardiovascular injury, and even death.
The diabetes drug Invokana has been linked to diabetic ketoacidosis (DKA), kidney problems, pancreatitis, cardiovascular risks, and bone fractures.
Type 2 diabetes drug Byetta is linked to an increased risk of pancreatic cancer in patients, but the drug's label does not warn about this side effect.
Xarelto has been linked to extreme bleeding events that have spawned thousands of lawsuits. Similar lawsuits have netted millions of dollars in compensation.
The blood thinner Pradaxa is linked to 1,000 deaths from uncontrollable bleeding. Boehringer Ingelheim has already paid $650 million in damages to plaintiffs.
The FDA says Abilify can cause compulsive gambling, shopping, eating, and sex. Abilify patients have filed lawsuits against drug maker Bristol-Myer Squibb.
Opioid lawsuits allege that doctors and drugmakers understated the addictiveness of painkillers. Some have been settled for hundreds of millions of dollars.
Invokana lawsuits are now awaiting trial in New Jersey. These bellwether trials will help determine if or when Janssen will settle the rest of these cases.
Johnson & Johnson has yet to settle its Invega lawsuits, but juries have awarded millions in damages for Risperdal, Invega's predecessor.
The antipsychotic drug Risperdal can cause young boys to develop female breast tissue. Many have filed lawsuits against J&J and received large awards.
Thousands filed lawsuits against Pfizer after allegedly developing type 2 diabetes from Lipitor. Most of those cases are still pending.
The diabetes drug Invokana may cause serious side effects like diabetic ketoacidosis (DKA), foot and leg amputations, and kidney problems.
Among other side effects, Risperdal can cause boys to develop breast tissue (gynecomastia). Thousands have filed lawsuits against Johnson & Johnson.
Merck's shingles vaccine Zostavax has been administered more than 36 million times. But, lawsuits allege that it may cause complications like eye disorders, paralysis, and even death.
The FDA has received thousands of adverse event reports for the popular blood thinner Xarelto, including cases of uncontrollable bleeding in patients, for which it lacks an antidote.